Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


New MS drug on the horizon

Posted 6 April 2021 AM

Janssen's multiple sclerosis drug Ponvory is among a handful of new therapies that appear to be nearing Australia.

It was one of four medicines recommended for approval in the CHMP's March meeting, although the FDA's approval just days ahead suggests the therapy is moving through regulatory processes quickly.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
All fine, nothing to see here
How politics made a mess of the rollout
Special Report
PBAC July Agenda
Committee to assess 36 submissions
Approvals Action
First copy of gout drug
Plus new formulations of PBS-listed drugs
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas